Reproductive Medicine

The WHO (World Health Organization) considers infertility a disease.

According to various estimates, infertility affects between 15% and 20% of couples in industrialised countries.

Worldwide, some 90 million people have fertility issues, of whom 25 million in Europe, the continent where artificial insemination has been substantially employed. In Europe, the number of administered treatment cycles rose from 100 thousand in 1995 to 700 thousand in 2014. In recent years, there has been a decrease in the fertility rate all around the world. Even in Africa, where the fertility rate remains the highest, births per woman slumped from 5.1 in 2000-2005 to 4.7 in 2010-2015.

Infertility has an indisputable social dimension. It cannot be relegated, as often the case, to a problem to be ashamed of that affects a minority of couples who are left to face their difficulties alone.

Medicine now offers a range of Medically-Assisted Procreation (MAP) solutions.

The IBSA infertility treatment portfolio includes highly-glycosylated gonadotropins of human origin produced using a unique purification process and progesterone in an aqueous solution.